TY  - JOUR
AU  - Kiburg, KV
AU  - Ward, GM
AU  - O'Neal, DN
AU  - MacIsaac, RJ
Y2  - 2021/09/17
Y1  - 2018/02/01
SN  - 1444-0903
UR  - http://hdl.handle.net/11343/283574
AB  - We documented temporal changes in the use of lipid-lowering medications and achievement of cholesterol targets in an Australian diabetes clinic. The number of patients using lipid-lowering therapy for primary or secondary cardiovascular prevention increased from 6 to 69% between 1993-1995 and 2014-2016, which corresponded to a decrease in low-density lipoprotein cholesterol levels from 3.7 to 2.4 mmol/L (P < 0.01).
LA  - English
PB  - WILEY
T1  - Lipid-lowering therapy use and achievement of cholesterol targets in an Australian diabetes clinic
DO  - 10.1111/imj.13691
IS  - Internal Medicine Journal
VL  - 48
IS  - 2
SP  - 201-204
L1  - /bitstream/handle/11343/283574/https%20onlinelibrary.wiley.com%20doi%20am-pdf%2010.1111%20imj.13691.pdf?sequence=1&isAllowed=y
ER  -